| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/08/2023 | -39.39% | Morgan Stanley | $5 → $4.6 | Maintains | Underweight |
| 08/28/2023 | 38.34% | Citigroup | → $10.5 | Initiates Coverage On | → Neutral |
| 05/11/2023 | -20.95% | Barclays | $7 → $6 | Maintains | Underweight |
| 03/09/2023 | -7.77% | Barclays | $5 → $7 | Maintains | Underweight |
| 03/08/2023 | 25.16% | Citigroup | $8.68 → $9.5 | Maintains | Neutral |
| 10/17/2022 | -34.12% | Morgan Stanley | $5.7 → $5 | Maintains | Underweight |
| 08/11/2022 | -34.12% | Barclays | $7 → $5 | Maintains | Underweight |
| 08/10/2022 | -24.9% | Morgan Stanley | $6 → $5.7 | Maintains | Underweight |
| 07/14/2022 | -7.77% | Citigroup | $10 → $7 | Maintains | Neutral |
| 06/15/2022 | -20.95% | Morgan Stanley | $8.7 → $6 | Maintains | Underweight |
| 05/17/2022 | 14.62% | Morgan Stanley | $9 → $8.7 | Maintains | Underweight |
| 05/12/2022 | 31.75% | Goldman Sachs | $14 → $10 | Maintains | Neutral |
| 05/11/2022 | 31.75% | Citigroup | $11 → $10 | Maintains | Neutral |
| 03/10/2022 | -7.77% | Barclays | $20 → $7 | Maintains | Underweight |
| 03/09/2022 | 18.58% | Morgan Stanley | $20 → $9 | Maintains | Underweight |
| 12/22/2021 | 242.56% | Citigroup | $32 → $26 | Maintains | Neutral |
| 11/11/2021 | 163.5% | Morgan Stanley | $29 → $20 | Maintains | Underweight |
| 10/01/2021 | 268.91% | Barclays | → $28 | Downgrades | Equal-Weight → Underweight |
| 08/17/2021 | — | Barclays | Downgrades | Overweight → Equal-Weight | |
| 08/13/2021 | 308.43% | Goldman Sachs | $37 → $31 | Downgrades | Buy → Neutral |
| 08/13/2021 | 282.08% | Morgan Stanley | $40 → $29 | Downgrades | Equal-Weight → Underweight |
| 06/11/2021 | 427.01% | Morgan Stanley | $30 → $40 | Downgrades | Overweight → Equal-Weight |
| 05/14/2021 | 295.26% | Morgan Stanley | $23 → $30 | Maintains | Overweight |
| 04/19/2021 | 203.03% | Morgan Stanley | → $23 | Initiates Coverage On | → Overweight |
| 04/19/2021 | 242.56% | Baird | → $26 | Initiates Coverage On | → Outperform |
| 04/19/2021 | 229.38% | Citigroup | → $25 | Initiates Coverage On | → Buy |
| 04/19/2021 | 361.13% | Goldman Sachs | → $35 | Initiates Coverage On | → Buy |
| 04/19/2021 | 242.56% | Barclays | → $26 | Initiates Coverage On | → Overweight |
What is the target price for Cricut (CRCT)?
The latest price target for Cricut (NASDAQ: CRCT) was reported by Morgan Stanley on November 8, 2023. The analyst firm set a price target for $4.60 expecting CRCT to fall to within 12 months (a possible -39.39% downside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cricut (CRCT)?
The latest analyst rating for Cricut (NASDAQ: CRCT) was provided by Morgan Stanley, and Cricut maintained their underweight rating.
When is the next analyst rating going to be posted or updated for Cricut (CRCT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cricut, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cricut was filed on November 8, 2023 so you should expect the next rating to be made available sometime around November 8, 2024.
Is the Analyst Rating Cricut (CRCT) correct?
While ratings are subjective and will change, the latest Cricut (CRCT) rating was a maintained with a price target of $5.00 to $4.60. The current price Cricut (CRCT) is trading at is $7.59, which is out of the analyst's predicted range.
